New directions in the prevention and treatment of schizophrenia: a biological perspective

Related Experiment Video

Updated: Oct 24, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

R J Wyatt1, J A Apud, S Potkin

  • 1Neuropsychiatry Branch, NIMH Neuroscience Center, St. Elizabeth's Hospital, Washington DC 20032, USA.

Psychiatry
|January 1, 1996
PubMed

Insights

Future treatments for schizophrenia will improve, offering better somatic therapies and potential preventive measures. Advances in genetics, perinatal care, and early intervention aim to reduce illness incidence and severity.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Genetics

Background:

  • Current schizophrenia treatments are primarily palliative, lacking effective preventive strategies.
  • Existing treatments are most effective when combined with psychosocial interventions.
  • No current preventive measures exist, except for counseling high-risk families.

Purpose of the Study:

  • To explore future advancements in schizophrenia treatment and prevention.
  • To identify key factors that may reduce schizophrenia incidence and severity.

Main Methods:

  • Review of modern genetics research.
  • Analysis of pre- and perinatal factors.
  • Evaluation of early and sustained intervention strategies.
  • Assessment of novel pharmacological treatments.

Main Results:

  • Anticipated improvements in somatic treatments for schizophrenia.
  • Potential introduction of preventive measures for schizophrenia.
  • Integration of biological and non-biological (psychosocial) approaches.

Conclusions:

  • Modern genetics, perinatal care, and early intervention hold promise for reducing schizophrenia.
  • Future treatments will likely combine biological and psychosocial strategies.
  • Advancements aim to decrease both the number of individuals affected and the illness's severity.

More Related Videos

Development of a Virtual Reality Assessment of Everyday Living Skills10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Related Concept Videos

Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications